Taxorest

Taxorest is a natural peptide bioregulator (cytomax) containing peptide complex A-19, derived from the bronchial mucosa of young, healthy animals. Developed within the Khavinson peptide research tradition at the St. Petersburg Institute of Bioregulation and Gerontology, it is designed to support the functional activity of the bronchopulmonary system.

What Is Taxorest?

Taxorest belongs to the class of tissue-specific peptide bioregulators (cytomaxes). It consists of low-molecular-weight peptides (typically under 5,000 Da) isolated from the mucous membrane of the bronchi. These peptides are claimed to act selectively on cells of the bronchial mucosa, helping normalize metabolism and regulate functional activity.

It is available primarily in capsule form (commonly 60 capsules) and also in a sublingual (lingual) liquid format for faster absorption. The product is positioned as a biologically active food supplement and source of peptides, not a pharmaceutical drug.

How Taxorest Peptides Work

According to the manufacturer and supporting literature:

• The peptides enrich the pool of regulatory peptides in bronchial mucosa tissue.
• They exert a tissue-specific effect, primarily targeting bronchial epithelial cells.
• Proposed actions include supporting cellular metabolism, antioxidant processes, adaptive capacity under stress, and restoration of functional activity after various challenges (environmental, infectious, or age-related).

This tissue-specific approach distinguishes cytomax-type products from broader systemic supplements.

Intended Uses and Potential Benefits

Manufacturer materials and clinical observations commonly associate Taxorest with support in the following areas (as a complementary measure alongside conventional care):

• Chronic bronchitis (including smoker’s bronchitis)
• Bronchial asthma
• Chronic obstructive pulmonary disease (COPD)
• Recovery after acute or chronic respiratory illnesses (including pneumonia)
• Support of respiratory function with aging
• Exposure to environmental pollutants or extreme factors
• Chronic cardiac deficiency where respiratory support may be relevant
• General maintenance of bronchopulmonary system function

Scientific Background

Taxorest has been the subject of clinical evaluation as a biologically active supplement. Studies have examined its effects on bronchial mucosa cell activity, tolerability, and use in respiratory conditions of various origins. Reports indicate good tolerance with no significant side effects noted in the studied populations when used as directed. It is described as having antioxidant properties and a favorable influence on adaptive capabilities.

Note that evidence levels and regulatory status differ by country. Taxorest is typically registered or marketed as a dietary/food supplement rather than a medicine.

How to Use Taxorest

Capsule form (typical recommendations):

• Adults: 1–2 capsules, 1–2 times daily (often before or with meals)
• Course duration: 30–60 days
• Repeat courses every 3–6 months as needed

Lingual (sublingual drops) form:

• Typically 5–6 drops under the tongue, several times daily before meals
• Course of about 1 month, with repeats every 3–6 months

Always follow the specific product label and consult a healthcare professional, especially if you have existing medical conditions or take other medications. Do not exceed recommended doses.

Safety and Contraindications

Taxorest is generally described as well-tolerated. Standard contraindications include:

• Individual intolerance to components
• Pregnancy
• Breastfeeding

Why Choose a Peptide Bioregulator Approach?

Tissue-specific peptide complexes like Taxorest represent a targeted strategy focused on cellular regulation rather than symptomatic relief alone. For individuals seeking support for bronchial and lung function—whether due to lifestyle factors (smoking history, pollution exposure), recovery needs, or age-related changes—Taxorest offers a natural peptide option rooted in decades of Russian bioregulation research.